Medical Devices UK

UK At-Home Fertility Tests Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

UK At-Home Fertility Tests Market Industry Trends and Forecast to 2034: Segmented by (Test, Format, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UK · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $19.3 Mn Placeholder estimate
Estimate 2025 $20.6 Mn 2.2% of the global market
Projected 2034 $38.3 Mn 85.4% Adds $17.6 Mn over 9 forecast years
CAGR 2025–2034 7.1% Faster than 55% of 193 Medical Devices markets here
Key players 6 Companies profiled
  • UK is 2.17% of the global market.
  • In Europe, the largest is Germany at $35.1 Mn.
  • Fastest growing: Russia at 9.4% a year.
  • UK ranks 4th of 6 by size in Europe.

Market size projection

UK

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$17.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
At-Home Fertility Tests Market market size by year, UK
YearMarket sizeChange that yearSince 2025
2024 (estimate) $19.3 Mn — —
2025 (base) $20.6 Mn +$1.4 Mn —
2026 (forecast) $22.1 Mn +$1.5 Mn +7.1%
2027 (forecast) $23.7 Mn +$1.6 Mn +14.7%
2028 (forecast) $25.4 Mn +$1.7 Mn +22.8%
2029 (forecast) $27.2 Mn +$1.8 Mn +31.6%
2030 (forecast) $29.1 Mn +$1.9 Mn +40.9%
2031 (forecast) $31.2 Mn +$2.1 Mn +50.9%
2032 (forecast) $33.4 Mn +$2.2 Mn +61.6%
2033 (forecast) $35.7 Mn +$2.4 Mn +73.1%
2034 (forecast) $38.3 Mn +$2.5 Mn +85.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

UK At-Home Fertility Tests Market Analysis at a glance
Market size, 2025$20.6 Mn placeholder estimate
Forecast, 2034$38.3 Mn placeholder estimate
Growth (CAGR), 2025–20347.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, format and end user (see all)
Key playersClearblue (SPD), Modern Fertility (Ro), Proov, Mira, Legacy and 1 more (see all)
Regulator in the UKMHRASource: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UK At-Home Fertility Tests Market Analysis Executive Summary

At-home fertility tests check hormones such as AMH, LH and progesterone, or sperm quality, to help people understand their fertility.

Key segments of the at-Home Fertility Tests market include test (Ovulation Tests, Hormone Panels and Sperm Tests) and format (Urine Strips, Finger-Prick Blood Kits and Digital Readers).

Bar chart: UK At-Home Fertility Tests market size, 2024–2034, placeholder estimates. $19.3 Mn in 2024, $20.6 Mn in 2025 and $38.3 Mn in 2034, 7.1% CAGR.
UK At-Home Fertility Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UK At-Home Fertility Tests Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the at-Home Fertility Tests market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the at-Home Fertility Tests market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the at-Home Fertility Tests market.

Competitive Landscape for At-Home Fertility Tests Market in the UK

The at-Home Fertility Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for At-Home Fertility Tests Market in the UK

At-Home Fertility Tests in the UK: rules and payment

Medical devices sold in Great Britain need UKCA or CE marking and registration with the Medicines and Healthcare products Regulatory Agency (MHRA).⁠[1] The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund.⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how at-Home Fertility Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the UK.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in At-Home Fertility Tests right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

At-Home Fertility Tests in context

The UK compared

  • Health spending per person: 5,860 US$ per person (2024). World: 1,317 US$ per person (2023). 7th highest of the 13 countries we cover in Europe.[1]
  • Doctors: 3.30 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 11th highest of the 13 countries we cover in Europe.[2]
  • People aged 65 and over: 19.7% of people (2025). World: 10.4% of people (2025). 11th highest of the 13 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Inside the UK

Quick answers

Frequently asked questions

How big is the At-Home Fertility Tests market in the UK?
Placeholder estimate: about $20.6 Mn in 2025, rising to about $38.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the At-Home Fertility Tests market in the UK growing?
Placeholder estimate: about 7.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the At-Home Fertility Tests market report cover?
The report splits the market by test (Ovulation Tests, Hormone Panels, Sperm Tests, Ovarian Reserve Tests), format (Urine Strips, Finger-Prick Blood Kits, Digital Readers) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the At-Home Fertility Tests market?
Key players include Clearblue (SPD), Modern Fertility (Ro), Proov, Mira, Legacy and Inito.
What is driving the At-Home Fertility Tests market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the at-Home Fertility Tests market. New products designed around women's biology and digital care are improving access.
Who regulates At-Home Fertility Tests in the UK?
Medical devices sold in Great Britain need UKCA or CE marking and registration with the Medicines and Healthcare products Regulatory Agency (MHRA). Source: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
How is healthcare paid for in the UK?
The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund. Source: National Institute for Health and Care Excellence. Checked 14 Nov 2026.
How much research is published on At-Home Fertility Tests?
PubMed lists 10 papers on At-Home Fertility Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in UK

See all

Related on fertility and diagnostics and lab testing

See the topic